Addus HomeCareADUS
Recorded

Addus HomeCare Stephens Annual Investment Conference 2026

Review the key takeaways and the transcript of this earnings call.

PeriodFY 2026Duration36 minParticipants3

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Raj KumarHealthcare Services Analyst

Looks like we are at the top of the hour, so we can get started. Welcome everyone to day one of the Stephens 2026 Annual Investment Conference, live and in person from Nashville. I am Raj Kumar, healthcare services analyst at Stephens. To start off our healthcare services fireside chats, we have Addus HomeCare, a leading provider of home-based care and support services, focusing on providing personal care, hospice, and home health services. Joining us here today from Addus are Dirk Allison, Chairman and CEO, and Brian Poff, EVP and CFO. I want to thank you both for joining us here at our conference today, and I think we will just jump right into Q&A, if that sounds good. Awesome. Yeah, maybe just to kick off the conversation, 2026 has kind of been a good year, I think, across all three lines of businesses.

Raj KumarHealthcare Services Analyst

As we kind of think about maybe going through a year in review, maybe kind of walk us through how 2026 has played out relative to kind of your internal expectations.

Dirk AllisonChairman and CEO

Sure. We think 2026 has been a good year for us, and like you mentioned, all three levels of care. It started out with a little bit of a cloud over the industry. I think with OB3 out there, people not understanding exactly how the Medicaid cuts were going to affect our business. We internally felt like, if you look at the work requirements, you look at the taxes that they were going to change, we did not feel like it would be a direct impact on our company. In fact, in the case of work requirements, we wondered would it be somewhat of a tailwind on hiring. So that was something I think the industry had to deal with. I think what we have seen as we have gone through the year, our performance financially has been pretty strong. We got our home health headed back in the right direction.

Dirk AllisonChairman and CEO

PCS has done well. We have had hourly growth. I think what has really reflected itself, we have not seen big negative impacts as it relates to OB3. We had one state out in the West, Montana, that has actually already put in work requirements. So it was a little bit of a test for us to see how would it affect the company. Really, what we would say is it has had no effect. We have not seen any decrease on the number of patients we have been able to bring into the system. The state has been able to handle the work requirements appropriately. On the other side, maybe it is still early, but 90 to 120 days in, we have not seen an influx of people looking to go to work either. So, I would say 2026 has been a good year.

Dirk AllisonChairman and CEO

We started the year believing there were going to be acquisition opportunities out there, especially in the PCS world this year. We were able to announce during the year, obviously, the AccentCare transaction, which we should close in the first quarter. So again, another opportunity that grows our business by about $280 million a year in revenue, which is another important aspect. So, pretty excited. We look forward to 2027 also. We think it's going to be another good year, not only from the standpoint of continued incremental improvements as we've seen, but also we think there'll be some acquisition opportunities we can take advantage of.

Raj KumarHealthcare Services Analyst

Got it. And maybe kind of table setting broadly for 2027. I guess kind of what are some of the puts and takes to keep in mind? I know you've talked about clinical acquisitions, but CMS extended the kind of moratorium, although there's some nuances there that provide some relief for existing licenses. Maybe just kind of talk about 2027 in that context and kind of how you see the M&A landscape in terms of you still being kind of able to execute on your kind of clinical acquisition targets or kind of what's in the pipeline as you kind of think about expansion in that business.

Dirk AllisonChairman and CEO

Sure. I think one of the exciting things is we've already got one of the big ones done. We should close AccentCare February is what we're hoping for. We've already passed antitrust, so we're just waiting on the additional regulatory approvals we need. We're in the process right now of meeting with their team. We've been very open developing the transition plan. That really allows us hopefully now to start looking at that next big deal out there. We're aware of two or three things that should be coming up in 2027. One of the things that we've done as a company, Brian Poff has done a very good job as our Chief Financial Officer, is keeping our balance sheet clean. When we close on AccentCare, we will still only be levered about one times EBITDA, so still have debt capacity to do other larger transactions.

Dirk AllisonChairman and CEO

We've already started talking to some folks, but as the processes get more official, we see opportunities to do some things. There's one or two PCS transactions we know are going to be out there, but as we talked about on the call, one of the things we'd like to do also is bring some more clinical services to the company. If you go back three or four years ago, we ran 25% or so of the business was clinical services with Gentiva closing and then followed by AccentCare, we're going to be down to about 18% on the clinical side. We'd like to get that up 25%-30%. So, we'll continue to look at personal care also. That's our main business, but we believe supplementing that with clinical services in 2027 is a real opportunity we're looking forward to.

Raj KumarHealthcare Services Analyst

Got it. As we kind of think about the midterms, just kind of, I'm going to be asking this of all of our companies here, but how do you kind of see the midterms in terms of the benefits to your business kind of broadly? Then maybe are you seeing any potential concerns from a policy perspective as we kind of see what the kind of Dems have kind of been wanting to do from a provider standpoint?

Dirk AllisonChairman and CEO

Our biggest challenge over the last couple years has been the federal government coming out, like with OB3 and taking Medicaid money away. It appears with the Democratic majority in the House and the Senate, that probably has gone away. They're talking about trying to do things such as eliminate or at least defer work requirements. We saw that come out this week where we got a six-month deferral. I think from a standpoint of the regulatory environment, we're in a little bit better position today than we might have been before. Democratic leadership has tended to put more dollars into Medicaid and the lower income benefits that we operate in for the majority of our business, so we're pretty excited about that. In most of our states, New Mexico, our three top large states, New Mexico and Illinois already had Democratic leadership.

Dirk AllisonChairman and CEO

Not much should change there with the exception of we should hopefully see continued rate increases. Maybe Illinois, we skipped a year. Hopefully we'll be back to getting that rate increase next year. The interesting one's Texas. Yeah.

Dirk AllisonChairman and CEO

We went from a red state, from a state standpoint, to a blue state in one election, for the first time in 30 years. The Republican leadership before had shown the last two biennial sessions that they've given us rate increases. We were already in the process with our lobbyists and our state association of talking to them about the next session starting in January of 2027 about getting a rate increase. Now it's going to be interesting to see how does having new Democratic leadership affect that. We would believe with Texas' rainy day fund and the funds they have, that maybe we can get some more dollars put into the elderly population, elderly and disabled population, but we'll see. All things being told, we think it's probably a little easier environment after the recent elections than maybe we faced before.

Raj KumarHealthcare Services Analyst

Got it. When I kind of think about Addus, it is like there is this value proposition of having these three levels of care, and you do not really see that, at least amongst other public companies that have personal care, home health, and hospice, at least to the scale that you guys have built up. I guess, what is the clearest evidence of having that three-service model, in terms of the benefit that you guys see across maybe cross-referrals? Clearly you have highlighted the bridge program with home health and hospice, but as I kind of think about longer term value to the payers in terms of value-based care, what is something that where you stand out more, when you even kind of do point-of-sale solutions relative to someone that is just a single-service operator?

Dirk AllisonChairman and CEO

Everybody thinks about it differently. I am talking about the provider, think of their business. We have always taken the approach that personal care is the one service that is in the elderly home the most. Where in home health, you might be in once a week, once every two weeks, depending on the plan of care. Certainly hospice is a different environment. But if you think of personal care, we are in there anywhere from three to five times a week. We are in there from two hours to four hours. We see this elderly patient every day, and we should be the first line of defense that sees if there are changes of condition. If you start thinking in terms of your payers, the payers' issue is these are a very high-cost member.

Dirk AllisonChairman and CEO

The elderly population, we are talking 75 years above, they are the ones that tend to go to the emergency room, readmits to the hospital. They are the ones that have difficulty getting to their PCP to have flu shots, other aspects taken care of, the kind of preventative measures to keep them from the higher-cost care. What we have been able to work with our payers on is, we can use the non-clinical base as a start, supplemented by the clinical services we are able to bring over to the top of that, to try to help them with value-based care. We have had a number of programs over the last few years that have proven, especially around two or three areas, readmits to hospitals after surgery, emergency room visits that can be avoided. There are certain emergency rooms you cannot, but some you can. Then closing care gaps. Like I said, the flu shots and the other things that might lead to hospitalizations if these patients are not able to access that particular kind of care.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Access every statement, the English original, and speaker-by-speaker history with StockNow Pro.

View the full transcript with Pro

Other earnings calls that day

View calls from this day